510(k) Report

510(k) · Cleared

Cleared

QT Ecg (QTERD100)

K233521510(k) SpecialCleared Dec 6, 202335-day reviewClass II21 CFR 870.2920

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

QT Medical, Inc. · DXH Transmitters And Receivers, Electrocardiograph, Telephone

Cleared on Dec 6, 2023 as substantially equivalent to K220795 (QT Medical, Inc., 2022) after a 35-day review. Its family tree reaches back 8 generations to 1997.

Decided
Dec 6, 2023
Review
35 days
Class
Class II
Product code
DXH
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K963725 (1997). 15 ancestors in all, the oldest K920984 (1992). No later device cites it as a predicate yet.

  1. Root · 8 generations backK963725 Model CG-2206 Personal Electrocardiogram (Ecg) Transmitter Device…Card Guard, Ltd. · 1997
  2. 7 generations backK012223 CG-2211 Selfcheck Ecg TransmitterCard Guard Scientific Survival, Ltd. · 2001
  3. 6 generations backK040942 VST3Biowatch Medical, Inc. · 2004
  4. 5 generations backK063609 River- 1 Electrocardiograph (Ecg) Recorder and TransmitterShl Telemedicine International, Ltd. · 2007
  5. 4 generations backK080047 Cardiosen'cShl Telemedicine International, Ltd. · 2008
  6. 3 generations backK113514 SmartheartShl Telemedicine International, Ltd. · 2012
  7. 2 generations backK180157 QT ECGQT Medical, Inc. · 2018
  8. 1 generation backK220795 QT ECGQT Medical, Inc. · 2022
  9. This deviceK233521 QT Ecg (QTERD100)QT Medical, Inc. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K963725Model CG-2206 Personal Electrocardiogram (Ecg) Transmitter Device (Modified)Card Guard, Ltd.1997—
−7K012223CG-2211 Selfcheck Ecg TransmitterCard Guard Scientific Survival, Ltd.2001—
−6K040942VST3Biowatch Medical, Inc.2004—
−5K063609River- 1 Electrocardiograph (Ecg) Recorder and TransmitterShl Telemedicine International, Ltd.2007—
−4K080047Cardiosen'cShl Telemedicine International, Ltd.2008—
−3K113514SmartheartShl Telemedicine International, Ltd.2012—
−2K180157QT ECGQT Medical, Inc.2018—
−1K220795QT ECGQT Medical, Inc.2022—
0 (this device)K233521QT Ecg (QTERD100)QT Medical, Inc.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199220
199710
199910
200010
200110
200210
FIG. 1 — Lineage of K233521, 1997–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXH device

  1. #1 K243438 MEMO Patch M (MPT-E08R-UNC01)score 12.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K220795QT ECG
Summary page 4
…Classification Product Code: DXH 12.4.4. Regulation number: 870.2920 12.4.5. Device Class: II 12.4.6. 510(k) Number: K220795 12.5. Indication for Use of the Device 12.5.1. Indication for Use: The QT ECG System is intended to acquire, record…
QT Medical, Inc.2022—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 5 companies; a new generation was cleared every 3.6 years on median.
  • 1 of the 15 ancestors has a recall of any class.

How does its category compare?

All DXH devices

DXH Transmitters And Receivers, Electrocardiograph, Telephone: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · DXH

4in 2025

2007: 32008: 72009: 22010: 22012: 12013: 32014: 62015: 42016: 12017: 52018: 42019: 62020: 52021: 32022: 42023: 12025: 42026 (partial year): 1
2007high 7 (2008) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXH

322in 2025

2007: 202 days median2008: 41 days median2013: 206 days median2014: 186 days median2015: 142 days median2017: 150 days median2018: 294 days median2019: 177 days median2020: 141 days median2021: 107 days median2022: 150 days median2025: 322 days median
2007high 322 (2025) · low 41 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXH

1in 2015

2008: 42011: 32015: 12026 (partial year): 1
2007high 4 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXH

27in 2025

2009: 12010: 42011: 12012: 12013: 12014: 12016: 52017: 42020: 52021: 22022: 62023: 42024: 22025: 27
2007high 27 (2025) · low 0 (2007)2025

MAUDE reports naming product code DXH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007320200
200874140
20092—01
20102—04
20110—31
20121—01
2013320601
2014618601
2015414210
20161—05
2017515004
2018429400
2019617700
2020514105
2021310702
2022415006
20231—04
20240—02
20254322027
20261—1—

What is it indicated for?

The QT ECG System is intended to acquire, record and process an electrocardiographic signal so that it can be transmitted digitally via Bluetooth technology to a cell-phone or mobile device, then to a remote location. The QT ECG System is indicated for use on infants, children and adults. It is designed to be operated by adults in the home, or by healthcare workers in non-acute care clinical facilities (such as nursing homes, skilled nursing facilities)…

Read the full statement (113 words)

The QT ECG System is intended to acquire, record and process an electrocardiographic signal so that it can be transmitted digitally via Bluetooth technology to a cell-phone or mobile device, then to a remote location. The QT ECG System is indicated for use on infants, children and adults. It is designed to be operated by adults in the home, or by healthcare workers in non-acute care clinical facilities (such as nursing homes, skilled nursing facilities), and in professional healthcare facilities (such as clinics, hospitals, and ambulances) to record and transmit a 12- lead ECG and rhythm strip in near real-time to enable review at a physician's office, hospital or other medical receiving centers.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K233521: QT Ecg (QTERD100).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233521

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026